The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer
- 1 September 2002
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 37 (3) , 303-309
- https://doi.org/10.1016/s0169-5002(02)00103-4
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Lack of Prognostic Significance of p53 and K-ras Mutations in Primary Resected Non–Small-Cell Lung Cancer on E4592: A Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant TherapyJournal of Clinical Oncology, 2001
- Lung Cancer in WomenChest, 2000
- A Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II or IIIa Non–Small-Cell Lung CancerNew England Journal of Medicine, 2000
- Sex differences in presentation, management, and prognosis of patients with non–small cell lung carcinomaThe Journal of Thoracic and Cardiovascular Surgery, 2000
- Sex-associated differences in survival of patients undergoing resection for lung cancerThe Annals of Thoracic Surgery, 2000
- Lung cancer in women compared with men: stage, treatment, and survivalThe Annals of Thoracic Surgery, 1998
- Longer survival after resection of non-small cell lung cancer in Japanese womenThe Annals of Thoracic Surgery, 1989
- A New International Staging System for Lung CancerChest, 1986
- A Network Algorithm for Performing Fisher's Exact Test in r × c Contingency TablesJournal of the American Statistical Association, 1983
- Clinical Staging of Primary Lung CancerAmerican Review of Respiratory Disease, 1983